Metcela

Developer of regenerative biological product for the treatment of heart failure

placeKanagawa, Kanto, Japan calendar_todayFounded 2016 groups7 employees language metcela.com

Social engagement

Social engagement: 381 social following, 8 posts in the last 12 months — top quartile of its industry.

Investor mix

13 investors on record; lead investors include UTEC, Japan Lifeline, Beyond Next Ventures, Cyberdyne.

Investor typeCountShare
Venture capital754%
Other / undisclosed646%

Hiring activity

Hires occasionally

2 roles tracked across 2 of the last 12 months

4 Mar 2026 · Business Development & Out-Licensing Advisor · United States

25 Feb 2026 · Clinical Program Manager · United States

Based on job postings tracked across public sources.

Recent activity

30 Jun 2026
Event
Bio Asia Taiwan 2026 Investment Summit
22 May 2026
Event
Metcela
3 Mar 2026
Event
25th Congress of the Japanese Society for Regenerative Medicine (JSRM)
Coming soon